The increase in human-wildlife interactions resulting from human encroachment into wildlife habitats will undoubtedly lead to increase in the opportunity for transmission of zoonotic diseases \[[@r23]\]. Rodents undeniably, play a central role in transmitting zoonotic diseases as they are the most abundant mammal and can be found in every continent except for Antartica \[[@r23]\]. Historical records have shown that rodents are linked to the spread of plague which drastically reduced human populations in Europe, Africa and Asia \[[@r7]\], highlighting the propensity of rodents to provoke major pandemics. The risks of emerging zoonoses to public health and the economy have provided impetus for pathogen surveillance initiatives, as early detection of zoonotic diseases is key to outbreak prevention.

Members of the bacteria genus *Bordetella* are closely related and are recognized for causing mild to severe respiratory disease in mammals \[[@r30]\]. The classical bordetellae; *B. pertussis*, *B. parapertussis* and *B. bronchiseptica* can cause respiratory disease in humans and livestocks \[[@r4]\], and receive the most research attention \[[@r13]\]. The other *Bordetella* subspecies, referred to as non-classical bordetellae, are mostly associated with the environment \[[@r13]\] and rodents \[[@r21]\], albeit more human infections have been recently reported \[[@r13]\]. The potential for inter-species transmission is considerable since a number of classical and non-classical bordetellae possess the ability to colonize and grow in rodents \[[@r21]\].

In Malaysia, there is a dearth of information on the genetic structure of bordetellae populations in wild rodents. Despite its zoonotic potential, no study has been conducted to investigate the diversity and clonal relationships among the bordetellae populations maintained in wild rodents. Reports of whooping cough and other pulmonary symptoms in humans living close to animals infected with *B. bronchiseptica* suggests that the infections originated from infected animals \[[@r12], [@r27], [@r32]\]. Even though there has not been any report of human *B. bronchiseptica* infection in Malaysia, all these past cases underscore the possibility of zoonotic transmission of bordetellae to humans or to other animals, and these animals can then serve as carrier in the transmission cycle \[[@r23]\]. Detection of *B. bronchiseptica* from livestock, domestic pets and wild animals in Africa, Asia, Europe and the U.S.A. have been documented, illustrating the global distribution of this species and the diversity of hosts it occupies \[[@r14], [@r25], [@r27], [@r33]\]. *B. pseudohinzii* also has a relatively wide geographical distribution evident by its recovery in Germany, Japan, Malaysia and the U.S.A., although this bacterium has only been isolated from laboratory-raised rodents \[[@r16]\].

Here, we recovered bordetellae from rodents captured in the wet markets and identified them to subspecies level using molecular tools. Multi locus sequence typing (MLST) and *nrdA* typing were utilized to determine the phylogenetic relationships among the different bordetellae isolates, which could shed useful insights into factors that shape the genetic structure of bordetellae. Sequence analysis of *nrdA*, encoding the ribonucleoside-diphosphate reductase alpha chain, has been demonstrated to reliably differentiate species within the *Bordetella* genus \[[@r21], [@r28]\]. In addition, the antimicrobial resistance and virulence profiles of the bordetellae isolates were also determined.

MATERIALS AND METHODS {#s1}
=====================

Rodent trappings
----------------

Prior approvals were obtained from the local municipal councils to accompany their pest eradication teams to conduct rodent trappings within wet markets in several states in Peninsular Malaysia. Wet markets in four states were included; Johor (1.4927° N, 103.7414° E), Kedah (6.1248° N, 100. 3678° E), Kelantan (6.1168° N, 102.2777° E) and Terengganu (5.3333° N, 103.1500° E) ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Map of Peninsular Malaysia showing the states that were involved in the study; Johor, Kedah, Kelantan and Terengganu, together with the number of bordetellae recovered, indicated below the names of each respective state. The table shows the number of rodents and shrews captured in the individual states.). Rodent trappings were conducted over a period of 14 months, from November 2014 until December 2015. Steel wire traps (18 × 12 × 28 cm) were placed on floors in the wet market in the evening with baits such as dried fish, bread or peanut butter. The traps were collected early in the morning before the market was opened \[[@r3]\]. All rodents were captured alive and their species were determined before they were euthanized at the field laboratory according to protocols described elsewhere \[[@r1]\]. Lung tissues were harvested and homogenized, followed by inoculation onto Columbia agar according to previously published methods \[[@r22]\]. Cross contamination between tissue specimens from different individual rodents was prevented by washing the surgical tools with alcohol, bleach and water, in between surgical procedures as previously described \[[@r20]\]. This study was approved with the ethics reference no. ISB/31/01/2013/SNMZ (R) by the Institutional Animal Care and Use Committee and did not involve any endangered or protected species.

Antimicrobial susceptibility testing and amplification of virulence genes
-------------------------------------------------------------------------

All mixed cultures grown from the rodent lung homogenates were sub-cultured until pure cultures were obtained. Chromosomal DNA of all pure-cultured bacteria isolates was extracted using NucleoSpin Tissue kit (Macherey-Nagel, Düren, Germany) according to the manufacturer's instructions. Subsequently, 16S rDNA sequencing \[[@r18]\] was performed to identify the respective isolates' species identity. Only members of the genus *Bordetella* were selected for this study and they were stocked in −80°C until further use. Antimicrobial susceptibility profiles were determined using M.I.C.Evaluator Strips (Thermo Fisher Scientific, Waltham, MA, U.S.A.) on Mueller-Hinton agar. The following antibiotics were utilized to determine the minimum inhibitory concentrations (MIC); amikacin, amoxicillin-clavulanic acid, ampicillin, ceftazidime, ciprofloxacin, ceftriaxone, cefotaxime, erythromycin, gentamicin, imipenem and meropenem. Antimicrobial susceptibility results were interpreted according to Clinical and Laboratory Standards Institute breakpoints for *Enterobacteriaceae* \[[@r5], [@r24]\]. The presence of the virulence genes; dermonecrotic toxin (*dnt*), exogenous ferric siderophore receptor (*bfrZ*) and flagella (*fla*), were examined using nucleic acid amplification protocols previously described \[[@r29]\].

Multi locus sequence typing and nrdA typing
-------------------------------------------

DNA fragments from seven housekeeping genes (*adk*, *fumC*, *glyA*, *tyrB*, *icd*, *pepA* and *pgm*) were amplified, trimmed to a standard length and compared with the *Bordetella* MLST database at <http://pubmlst.org/bordetella/> \[[@r6]\]. A novel allele number was assigned to allele sequences that are not available in the database, resulting in the assignment of a novel ST. An additional *nrdA* typing method \[[@r28]\] was performed on bordetellae which failed MLST characterization \[[@r21]\]. This method was also applied to the other *Bordetella* isolates and sequences of all *nrdA* loci were extracted from the database, aligned and phylogenetically analyzed using MEGA 5.2.

Analysis of evolutionary relationships
--------------------------------------

The evolutionary relationships among bordetellae in this study, were analyzed and presented as a minimum spanning tree using the algorithm, PHYLOViZ \[[@r9]\]. The displayed minimum spanning tree was used to visualize the possible evolutionary relationships between *Bordetella* isolates based on their MLST allelic profile data. The minimum spanning tree firstly, links STs sharing single locus variants and the subsequent branches connect to STs with more than one locus variation. STs located multiple branches away from the core ST have the most loci variants.

Amplification of the CRISPR-cas locus
-------------------------------------

A Type II-C CRISPR-Cas system was recently discovered in a newly described bordetellae, *B. pseudohinzii* \[[@r15]\]. CRISPR-Cas systems have not been identified in any other *Bordetella* species, making the amplification of genes associated to the Type II-C CRISPR-Cas system a defining feature for the identification of *B. pseudohinzii*. Nucleic acid amplification of the Type II-C CRISPR associated genes was performed on bordetellae which could not be characterized using MLST \[[@r15]\].

RESULTS {#s2}
=======

A total of four Malaysian states were included in this study (Johor, Kedah, Kelantan and Terengganu). Two types of rodent species were caught from the four states; *Rattus norvegicus* (n=177) and *Rattus rattus diardii* (n=100), with Kelantan having the most number of captured rats (n=143), followed by Terengganu (n=58), Kedah (n=57) and Johor (n=19). *Rattus norvegicus* dominated the number of captured rats in Kelantan (n=99), followed by Terengganu (n=38), Johor (n=19) and Kedah (n=21). The most number of *Rattus rattus diardii* was captured in Kelantan (n=44), followed by Kedah (n=36) and Terengganu (n=20). There was no *Rattus rattus diardii* trapped in Johor ([Fig. 1](#fig_001){ref-type="fig"}). Several shrews (n=7) were trapped in Kelantan, however, they were omitted as this species was not included in the animal ethics application.

Analyses of the bacterial isolates cultured from rat lung homogenates using 16S rDNA sequencing revealed the isolation of 4 *Bordetella* isolates, yielding the prevalence of bordetellae at 1.44%. Based on the partial 16S rDNA sequences, the isolates were identified as *B. bronchiseptica* (n=3) and *B. hinzii* (n=1) ([Table 1](#tbl_001){ref-type="table"}Table 1.Antimicrobial susceptibilities, sequence types, *nrdA* loci and host diversity of bordetellae recovered from wild rodentsIsolate name\
(*Bordetella* species)HostVirulence geneST*nrdA* locusMIC (*µ*g/m*l*)AMKAMCAMPCAZCIPCROCTXERYGENIMPMEMTRE151600\
(*B. bronchiseptica*)RR*dnt*, *bfrZ*, *fla*82162S (16)R (256)R (128)S (0.5)S (0.5)R (8)R (16)R (8)S (1)S (0.06)S (0.03)TRE150202\
(*B. bronchiseptica*)RR*dnt*, *bfrZ*, *fla*82162S (4)R (128)R (64)S (0.06)S (0.25)R (16)R (16)R (8)S (2)S (0.5)S (0.5)TRE155202\
(*B. bronchiseptica*)RN*dnt*, *bfrZ*, *fla*82162S (8)R (256)R (64)S (0.5)S (0.12)R (16)R (32)R (8)S (1)S (0.25)S (0.25)TRE152202\
(*B. pseudohinzii*)RRnana189S (8)R (128)R (128)S (0.03)S (0.25)R (8)R (16)S (0.5)S (0.5)S (0.06)S (0.06)RR, *Rattus rattus diardii*; RN, *Rattus norvegicus*; *dnt*, dermonecrotic toxin; *bfrZ*, exogenous ferric siderophore receptor; *fla*, flagella; ST, sequence type; na, not available; MIC, minimum inhibitory concentration; AMK, amikacin; AMC, amoxicillin-clavulanic acid; AMP, ampicillin; CAZ, ceftazidime; CIP, ciprofloxacin; CRO, ceftriaxone; CTX, cefotaxime; ERY, erythromycin; GEN, gentamicin; IMP, imipenem; MEM, meropenem; R, resistant; S, sensitive.). These four bordetellae were isolated from Terengganu rats. *Rattus rattus diardii* harbored three isolates (2 *B. bronchiseptica* and 1 *B. hinzii*), while the other *B. bronchiseptica* was isolated from the lung of one *Rattus norvegicus* ([Table 1](#tbl_001){ref-type="table"}). The *B. bronchiseptica* isolates (TRE151600, TRE150202 and TRE155202) were subjected to MLST and *nrdA* typing, whereas only the *nrdA* typing was performed on isolate TRE152202 ([Table 1](#tbl_001){ref-type="table"}). Genotyping analyses uncovered that all of the *B. bronchiseptica* isolates as ST82 (novel ST) possessing *nrdA* locus 162 ([Table 1](#tbl_001){ref-type="table"}). Isolate TRE152202 was shown to possess *nrdA* locus 189, corresponding to *Bordetella* genogroup 16 ([Table 1](#tbl_001){ref-type="table"}). Upon obtaining this finding, the extracted DNA of isolate TRE152202 was used for the amplification and sequencing of the CRISPR-*cas* locus. Amplicons of the *cas1*, *cas2* and *cas9* were amplified ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Nucleic acid amplification products of *cas9*, *cas1* and *cas2* of *B. pseudohinzii* TRE152202. Lane 1, *B. pseudohinzii* BH370 (positive control); Lane 2, *B. pseudohinzii* TRE152202; Lane 3, *B. bronchiseptica* TRE151600; Lane 4, *B. bronchiseptica* TRE150202; Lane 5, *B. bronchiseptica* TRE155202.) and all displayed identical sequences as the CRISPR-associated genes of *B. pseudohinzii* HI4681 (accession no. CP016440) and BH370 \[[@r19]\]. Isolate TRE152202 was thus, redesignated as *B. pseudohinzii*.

The population structure among *B. bronchiseptica* isolated in this study was examined by building a minimum spanning tree using an established algorithm, PHYLOViZ. The ST82 isolates were shown to have evolved from the central ST6-lineage ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Minimum spanning tree of *B. bronchiseptica* complex I, constructed using PHYLOViZ. Each circle represents individual STs and different colors indicate the host at which *B. bronchiseptica* was recovered. ST and hosts data were recovered from the *Bordetella* MLST database at <http://pubmlst.org/bordetella/>. The novel ST82 was indicated by a circle with dashed lines.). As depicted in [Fig. 3](#fig_003){ref-type="fig"}, all of the STs were also members of the *B. bronchiseptica* complex I, which consists of predominantly animal-associated isolates. Based on the constructed phylogenetic tree using the trimmed 765-bp *nrdA* gene, we observed that the classical and non-classical bordetellae were distinctively separated into 3 clusters ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.Neighbor-joining tree based on *nrdA* loci of classical and non-classical bordetellae. *nrdA* locus numbers are indicated behind the bordetellae species names. The *nrdA* locus numbers were extracted from the *Bordetella* MLST database at <http://pubmlst.org/bordetella/>. Bordetellae isolates which have not been classified to the species level were excluded from the study. Separation of complexes I-IV in the classical bordetellae group based on MLST data was consistent with the *nrdA* sequence analyses. All non-classical bordetellae were clustered separately.); one belonging to the classical bordetellae, one belonging to non-classical bordetellae, of which has been partially characterized and one belonging to the recently discovered non-classical bordetellae (*B. bronchialis*, *B. flabilis* and *B. sputigena*). Two sub-clusters were noted among the classical bordetellae; one containing predominantly human isolates (*B. bronchiseptica* complex IV and *B. pertussis* complex II) and the other consists of predominantly animal isolates (*B. bronchiseptica* complex I and *B. parapertussis* complex III) ([Fig. 4](#fig_004){ref-type="fig"}). The *B. bronchiseptica* isolates carrying *nrdA* locus 162 were clustered together with *B. bronchiseptica* complex I and *B. parapertussis* complex III. The *B. pseudohinzii* isolate carrying *nrdA* locus 189, however was clustered together with the non-classical bordetellae ([Fig. 4](#fig_004){ref-type="fig"}).

Antimicrobial susceptibility testing performed on the *Bordetella* isolates showed that they had almost similar antimicrobial profiles. Resistance was displayed towards amoxicillin-clavulanic acid, ampicillin, ceftriaxone and cefotaxime. All of the *Bordetella* isolates were susceptible to amikacin, ceftazidime, ciprofloxacin, gentamicin, imipenem and meropenem ([Table 1](#tbl_001){ref-type="table"}). The only observed antimicrobial disparity was on erythromycin, by which the *B. bronchiseptica* isolates displayed resistance while *B. pseudohinzii* was susceptible ([Table 1](#tbl_001){ref-type="table"}). Additionally, the *B. bronchiseptica* isolates carried the virulence genes; *dnt*, *bfrZ* and *fla*, while *B. pseudohinzii* did not carry any ([Table 1](#tbl_001){ref-type="table"}).

DISCUSSION {#s3}
==========

Even though rats were implicated as the host for *B. bronchiseptica* \[[@r2]\], the prevalence of this species in the Malaysian wild rat population is unknown. The overall prevalence of bordetellae in rodents from the four Malaysian states was 1.44% (4/277), slightly higher as compared to the findings by Jiyipong *et al*. (2013) where only one bordetellae was cultured out of 206 rodent specimens yielding a prevalence of 0.49% \[[@r17]\]. This was also consistent with the reported low prevalence of *B. bronchiseptica* carriers in rodent populations \[[@r2]\] and a well-fed population of rats in the market would have developed stronger immunological defenses, reducing *B. bronchiseptica* infection risk \[[@r8]\]. The isolation of bordetellae from the lung tissues of *Rattus norvegicus* and *Rattus rattus diardii* suggests that these two rodent species were competent hosts and indicated the propensity of this bacterial genus to the respiratory tract, similar to other reports \[[@r4], [@r30]\]. Only rats from the state of Terengganu harbored bordetellae and this was to be expected due to the low prevalence of this bacterium in the host \[[@r2]\] coupled with the limited number of study sites. The absence of *Rattus rattus diardii* in Johor probably reflected the sampling limitation in this study whereby trappings were conducted for only one night and rat species with low abundance was not captured. Identification of bordetellae using a three-pronged approach (16S rDNA sequencing, *nrda* typing and MLST) ensures resolution to the species level, at least for the classical bordetellae \[[@r21]\], owing to the close phylogenetic relationships within the genus \[[@r28]\]. It has been reported that rodents are unnatural hosts for *B. bronchiseptica* although they can be colonized and shed the bacteria \[[@r30]\]. Rats have been shown to demonstrate strong resistance towards clinical infection by *B. bronchiseptica*, however they become asymptomatic carrier for life after exposure \[[@r2]\], similar to our observation of the seemingly healthy captured rats. *B. bronchiseptica* can remain within the respiratory epithelial cells to evade the host's immune system \[[@r10]\] contributing to life-long disease persistence in infected rats.

The *B. bronchiseptica* isolates recovered from *Rattus norvegicus* and *Rattus rattus diardii* ([Table 1](#tbl_001){ref-type="table"}) displayed identical genotype (ST82; *nrdA* locus 162), suggesting inter-species *B. bronchiseptica* transmission between rats in that particular area. This contradicts the earlier suggestion that *B. bronchiseptica* transmission does not occur between wild type host \[[@r30]\], although colonization of hosts can be affected by the different physiological responses between mice and rats \[[@r20]\] and/or *B. bronchiseptica* strain variations \[[@r4]\]. Alternatively, *B. bronchiseptica* recovered from rats in this study could be transmitted by other animals in the market, as the bacterium is highly contagious among poultry and livestock \[[@r30]\]. This species can also survive in the environment and on inanimate surfaces \[[@r2], [@r30]\], possibly aiding the spread and transfer to other mammals. *nrdA* typing identified isolate TRE152202 as *Bordetella* genogroup 16 possessing *nrdA* locus 189 after the inability of 16S rDNA sequencing and MLST to resolve its species identity ([Table 1](#tbl_001){ref-type="table"}). We have previously isolated a similar bordetellae with *nrdA* locus 189 \[[@r21]\] and this isolate was recently classified as *B. pseudohinzii* \[[@r19]\]. This species can be differentiated from the other bordetellae by the amplification of the Type II-C CRISPR-Cas system ([Fig. 2](#fig_002){ref-type="fig"}), exclusively found in *B. pseudohinzii* \[[@r15]\]. Initially found only in laboratory mice \[[@r15], [@r16], [@r19], [@r21]\], we have now established that *B. pseudohinzii* also reside in the lung of wild rats, although the clinical significance remains unclear.

The *nrdA*-based phylogeny \[[@r28]\] ([Fig. 4](#fig_004){ref-type="fig"}) displayed a congruent clustering of *Bordetella* complexes with the MLST-based phylogeny. The first cluster comprised *B. bronchiseptica* complex IV and *B. pertussis* complex II, and the second cluster comprised *B. bronchiseptica* complex I and *B. parapertussis* complex III. The bordetellae population structure inferred from *nrdA* typing concurred with the MLST-based phylogeny, affirming that *B. parapertussis* and *B. pertussis* evolved from *B. bronchiseptica* complex I and IV, respectively \[[@r6]\]. In addition, the non-classical bordetellae formed a separate cluster, demonstrating excellent *Bordetella* subspecies demarcation using the *nrdA*-based phylogeny \[[@r28]\] ([Fig. 4](#fig_004){ref-type="fig"}).

Based on the MLST *Bordetella* phylogeny ([Fig. 3](#fig_003){ref-type="fig"}), the novel ST82 clustered together with other clones from complex I \[[@r6]\], which included isolates from humans and animals. A high possibility of zoonotic transmission can be anticipated with ST82 isolates as they are closely related to other STs (ST4, ST7, ST11, ST12, ST23, ST27 and ST55) ([Fig. 3](#fig_003){ref-type="fig"}) which were recovered from humans \[[@r4], [@r6], [@r27]\]. Transmission from infected animals to humans can occur through inhalation of aerosols or by contact with respiratory secretions \[[@r10]\]. Animals may not show apparent clinical symptoms of *B. bronchiseptica* infection however, human-adapted strains may modulate their virulence differently and lead to respiratory illnesses \[[@r4]\], augmenting the risk to humans. ST27 from a household cat, for example, was strongly suspected to be the source of *B. bronchiceptica* infection in a child \[[@r27]\] and a *B. bronchiseptica* strain originating from companion animals was suggested to infect and, transmit between humans who were in close contact with each other \[[@r14]\]. Human to human transmission, hence, is possible via contact with respiratory droplets \[[@r10]\].

Antimicrobial susceptibility testing revealed that *B. bronchiseptica* and *B. pseudohinzii* had almost similar antimicrobial profiles, reflecting the close phylogenetic relationships between the two bordetellae. The only antimicrobial susceptibility variance between *B. bronchiseptica and B. pseudohinzii* was observed using the macrolide; erythromycin, where it was ineffective against *B. bronchiseptica* although it was reported to be effective for the treatment of most *Bordetella* clinical infections \[[@r31]\], including *B. pseudohinzii* in this study. Resistance to erythromycin could be an innate phenotype of *B. bronchiseptica* as this was also observed among *B. bronchiseptica* isolates from pigs with respiratory diseases in China \[[@r33]\]. The anti-pseudomonal cephalosporin; ceftazidime, was effective for the eradication of *B. bronchiseptica* and *B. pseudohinzii*, similar to other reports \[[@r21], [@r32]\]. The isolates were however, susceptible to the third generation cephalosporins, cefotaxime and ceftriaxone, in agreement with a previous case of suspected *B. bronchiseptica* transmission from a kitten \[[@r26]\] and *B. pseudohinzii* BH370 recovered from ICR mouse \[[@r21]\]. Both bordetellae appeared to be susceptible to aminoglycosides (amikacin and gentamicin), carbapenem (imipenem and meropenem) and fluoroquinolone (ciprofloxacin), comparable to *B. bronchiseptica* human infections \[[@r11], [@r14], [@r32]\] and *B. pseudohinzii* BH370 \[[@r21]\]. In accordance with a previous study on human clinical isolates \[[@r32]\], our *B. bronchiseptica* isolates displayed identical resistance towards ampicillin and amoxicillin-clavulanic acid. *B. pseudohinzii* BH370 \[[@r21]\], 8-296-03^T^ \[[@r16]\] and TRE152202 (this study) exhibited analogous resistance to ampicillin and even though 8-296-03^T^ was not tested against amoxicillin-clavulanic acid \[[@r16]\], it was expected to display resistance similar to BH370 and TRE152202, suggesting that the difference in hosts did not influence antimicrobial properties. The nucleic acid amplification of *dnt*, *bfrZ* and *fla* from *B. bronchiseptica* but not *B. pseudohinzii* may reflect the roles of these genes in host colonization \[[@r29]\], catering to the broad host range for *B. bronchiseptica*.

Considered together, the much overlooked bordetellae surveillance despite the low prevalence among wild rats in Malaysia is a cause for concern as bordetellae such as *B. bronchiseptica* can be highly contagious in nature \[[@r30]\], persistent \[[@r12]\] and has a wide host range \[[@r2]\]. The persistence of this species in the host predisposes it to progressively acquire antimicrobial resistance \[[@r11]\] that could exacerbate pre-existing clinical conditions \[[@r27]\]. Upon browsing the *Bordetella* MLST database at <http://pubmlst.org/bordetella/>, we noticed that the novel *B. bronchiseptica* ST82 was the sole complex I representative from Asia, reflecting the neglected state of research on this species. The significant finding of *B. pseudohinzii* in wild rat is important as this species was previously thought to specifically infect laboratory mice \[[@r16]\]. Although the clinical significance remains unknown and prevalence is low, the potential for pathogen transmission from the wild to the laboratory is possible and this could have serious implications for studies using these infected animals. It is therefore important to study the genetic composition and prevalence of bordetellae in urban rats for comparison with other geographical regions to ensure early identification of pathogens capable of causing public health disorder.

This work was supported by the University of Malaya Research Grant (RP016C-14AFR and RU005-2017) and the High Impact Research-Ministry of Higher Education Grant (E000013-20001).
